Brain Health
Blood Test Predicts Alzheimer's Onset Years Before Memory Loss Begins
New p-tau217 blood test forecasts Alzheimer's symptoms within 3-4 years, potentially revolutionizing early intervention strategies.
Press Release
Mar 28, 2026 2
Results for "Plasma p-tau217"
20 articles
Longevity & Aging
New Tau Antibody Deal Could Sharpen Early Alzheimer's Diagnosis
A licensing deal for 9 specialized Tau antibodies may help distinguish Alzheimer's from other brain diseases years before symptoms appear.
Press Release
Jun 13, 2026 0
Longevity & Aging
Tau Protein Unlocks Long-Term Memory Encoding in Healthy Brains
Scientists discover tau isn't just an Alzheimer's villain — it's essential for encoding lasting memories in healthy neurons.
Press Release
May 27, 2026 0
Longevity & Aging
Buntanetap Shows Cognitive Gains in Early Alzheimer's Patients With Key Biomarker
New Phase 2/3 trial data show buntanetap improved cognition in early-stage Alzheimer's patients positive for pTau217, hinting at disease-modifying effects.
Press Release
May 5, 2026 0
Regenerative Medicine
Biogen's Anti-Tau Alzheimer's Drug Misses Phase 2 But Shows Hints of Promise
BIIB080 failed its primary endpoint in Phase 2, yet Biogen sees potential signals worth pursuing in the fight against Alzheimer's tau tangles.
Press Release
May 15, 2026 0
Brain Health
Hidden Brain Cells May Hold Key to Preventing Alzheimer's Tau Protein Buildup
Scientists discover tanycytes help clear toxic tau from the brain. When damaged, these cells may allow Alzheimer's progression.
Press Release
Mar 29, 2026 1
Longevity & Aging
Columbia Scientists Uncover Neuron Protein System Tied to Alzheimer's Tau Tangles
A neuron-specific protein disposal mechanism may explain why normal tau protein clumps in sporadic Alzheimer's disease, new research reveals.
Press Release
Jun 6, 2026 0
Longevity & Aging
Single Gene Therapy Shot Cuts Alzheimer's Tau Protein by 64% in Primates
Voyager's VY1706 slashed tau protein up to 64% in primate brains after one IV dose, with no adverse effects found.
Press Release
May 15, 2026 0
Longevity & Aging
Plasma Exchange Therapy Cuts Biological Age by 2.6 Years in Clinical Trial
A first-of-its-kind trial shows therapeutic plasma exchange plus IVIG reduced biological age by an average of 2.6 years, confirmed by multi-omics analysis.
Press Release
May 23, 2026 0
Longevity & Aging
FDA Greenlights First Tau-Targeting Gene Therapy Trial for Early Alzheimer's
Voyager's one-time IV gene therapy slashed tau protein by 75% in primates. Human trials begin late 2026.
Press Release
Jun 4, 2026 0
Brain Health
Brain's Hidden Tau Cleanup System Could Block Alzheimer's Damage
UCLA scientists discover why some neurons resist Alzheimer's better than others, revealing a natural protein cleanup system that could lead to new treatments.
Press Release
Mar 29, 2026 0
Longevity & Aging
Tau-Targeting Alzheimer's Drug Shows First Phase 2 Evidence of Slowing Cognitive Decline
Diranersen reduced tau biomarkers and slowed cognitive decline in early Alzheimer's patients, marking a milestone for tau-directed therapy.
Press Release
May 16, 2026 0
Longevity & Aging
Oral Alzheimer's Drug Buntanetap Shows Cognitive Gains and Biomarker Shifts in Phase 2/3 Trial
Annovis's buntanetap reduced tau and neuroinflammation markers while improving cognition in mild Alzheimer's patients across a 12-week trial.
Press Release
Apr 30, 2026 0
Longevity & Aging
Oligomerix Completes Phase 1a Trial of Oral Tau-Targeting Alzheimer's Pill
New York biotech reports a favorable safety profile for OLX-07010, an oral drug designed to stop toxic tau protein clumping in the brain.
Press Release
May 23, 2026 0
Longevity & Aging
Alzheimer's Blood Tests and AI Screening Are Reshaping Early Detection
New commercial screening bundles and at-home blood sampling tech are pushing Alzheimer's detection years before symptoms appear.
Press Release
May 22, 2026 0
Brain Health
Alzheimer's May Start With Protein Hijacking, Not Just Plaque Buildup
UC Riverside researchers show amyloid beta may displace tau from neurons, triggering brain cell breakdown before plaques even form.
Press Release
Jun 19, 2026 0
Longevity & Aging
First Tau Gene Therapy Cleared by FDA Targets Alzheimer's at the Source
Voyager's VY1706 aims to reduce tau protein production in the brain with a single IV dose — a potential shift in Alzheimer's treatment strategy.
Press Release
Jun 17, 2026 0
Longevity & Aging
Oral Alzheimer's Drug Passes First Human Safety Study With Promising Results
OLX-07010, a novel tau-targeting pill, cleared Phase 1a safety trials in 76 adults, hitting blood levels linked to efficacy in animal models.
Press Release
May 22, 2026 0
Longevity & Aging
At-Home Fingerprick Test Could Detect Alzheimer's Risk Years Before Symptoms
A new Nature Communications study shows self-collected fingerprick blood tests reliably flag Alzheimer's biomarkers, enabling earlier risk detection.
Press Release
May 15, 2026 0
Brain Health
New Blood Test Detects Alzheimer's by Reading Protein Shape Changes
Scientists discover that subtle changes in blood protein structure can identify Alzheimer's earlier than current tests.
Press Release
Mar 28, 2026 3
Page 1 of 2Next